Search clinical trials for: Enfortumab vedotin
Total 417 results
-
Seagen Inc.Merck Sharp & Dohme LLC; RemeGen Co., Ltd.RecruitingUrothelial CarcinomaUnited States, Canada, Taiwan, Australia, Singapore
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingHR Positive/HER2 Low Expression Metastatic Breast CancerChina
-
TakedaRecruitingT-Cell LymphomaFrance, Germany, Spain, Italy
-
Wuhan Union Hospital, ChinaRecruitingBreast Cancer | Neoadjuvant TherapyChina
-
Sun Yat-sen UniversityNot yet recruitingNon Small Cell Lung Cancer | ERBB2 Mutation-Related Tumors | RC48 | Disitamab VedotinChina
-
Tianjin Medical University Second HospitalRecruiting
-
Jennifer Crombie, MDGenentech, Inc.RecruitingLymphoma | Lymphoma, Large B-Cell, DiffuseUnited States
-
Institut für Klinische Krebsforschung IKF GmbH...Charite University, Berlin, Germany; Roche Pharma AG; Hoffmann-La Roche; Arbeitsgemeinschaft... and other collaboratorsRecruitingLymphoma, Large B-Cell, DiffuseGermany, Austria
-
Chunguang yang (101937)RecruitingUrothelial Carcinoma | Radical CystectomyChina
-
West China HospitalNot yet recruiting
-
Tianjin Medical University Cancer Institute and...Not yet recruiting
-
National Cancer Institute (NCI)RecruitingLugano Classification Limited Stage Hodgkin Lymphoma AJCC v8United States, Puerto Rico, Canada
-
Shen LinRemeGen Co., Ltd.Not yet recruitingAdvanced Solid Tumor | Advanced Gastric Cancer | Advanced Gastroesophageal Junction Adenocarcinoma | HER2China
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI); Genentech, Inc.RecruitingDiffuse Large B-Cell Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Grade 3b Follicular Lymphoma | Transformed Follic Lymph to Diff Large B-Cell Lymphoma | Transformed Marg Zone Lymph to Diff...United States
-
Tianjin Medical University Cancer Institute and...Not yet recruiting
-
M.D. Anderson Cancer CenterRecruitingHodgkin Lymphoma | B-Cell Lymphoma | Relapsed B-cell NHLUnited States
-
Hospital Regional de Alta Especialidad del BajioUniversidad de GuanajuatoRecruitingHodgkin Lymphoma | Refractory Hodgkin Lymphoma | Relapsed Hodgkin's Disease, AdultMexico
-
Qilu Hospital of Shandong UniversityNot yet recruitingHER2-positive Gastric CancerChina
-
Sun Yat-sen UniversityRecruiting
-
The First Affiliated Hospital with Nanjing Medical...Recruiting
-
UNC Lineberger Comprehensive Cancer CenterGenentech, Inc.RecruitingDiffuse Large B-cell LymphomaUnited States
-
Tianjin Medical University Second HospitalRecruitingHer2 Overexpressing High-Risk Non-Muscle Invasive Bladder Urothelial CarcinomaChina
-
The First Affiliated Hospital with Nanjing Medical...RecruitingColorectal NeoplasmsChina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNanfang Hospital of Southern Medical University; The Third Affiliated Hospital... and other collaboratorsNot yet recruiting
-
TakedaRecruitingHodgkin LymphomaJapan
-
Merck Sharp & Dohme LLCRecruitingFollicular Lymphoma | Mantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Richter Transformation LymphomaPoland, United States, Canada, China, Estonia, Israel, Italy, Korea, Republic of, Spain, Sweden, Turkey, Czechia, Germany, Chile, Brazil, Portugal, Ireland, Singapore, United Kingdom, Japan, Peru
-
University of WashingtonRecruitingDiffuse Large B-Cell Lymphoma | High Grade B-Cell Lymphoma | Grade 3b Follicular LymphomaUnited States
-
University of Alabama at BirminghamSeagen Inc.; Kyowa Kirin, Inc.RecruitingMycosis Fungoides | Cutaneous T Cell LymphomaUnited States
-
Washington University School of MedicineGenentech, Inc.; Institute for Follicular LymphomaRecruitingLymphoma, Follicular | Follicular LymphomaUnited States
-
Merck Sharp & Dohme LLCRecruitingLymphoma, Large B-Cell, Diffuse (DLBCL)Italy, Canada, Israel, Korea, Republic of, Poland, Spain, Turkey
-
University of VirginiaMerck Sharp & Dohme LLCRecruitingClassical Hodgkin LymphomaUnited States
-
M.D. Anderson Cancer CenterSeagen Inc.Recruiting
-
The First Affiliated Hospital of Zhengzhou UniversityBeiGene; Jiangsu Hengrui Pharmaceutical Co., Ltd.; RemeGen Co., Ltd.Not yet recruitingHER2-positive or Mutated Advanced Colorectal Cancer
-
Shanghai Zhongshan HospitalNot yet recruitingColorectal Neoplasms
-
Shanghai Zhongshan HospitalTakeda; BeiGeneNot yet recruiting
-
Yale UniversityMerck Sharp & Dohme LLCRecruitingT-Cell LymphomaUnited States
-
RemeGen Co., Ltd.RecruitingUrothelial Carcinoma | HER2-expressingChina
-
GenmabAbbVieRecruitingNon-Hodgkin LymphomaUnited States, France, Israel, Korea, Republic of, Spain, Taiwan, Netherlands, Czechia, Japan, Hungary, Germany, Denmark
-
BioAtla, Inc.RecruitingHead and Neck Cancer | Metastatic Cancer | Squamous Cell Carcinoma of Head and Neck | Recurrent Squamous Cell Carcinoma of the Head and Neck | Metastatic Squamous Cell Carcinoma of the Head and NeckUnited States
-
Lazaros LekakisGenentech, Inc.RecruitingRefractory Non-Hodgkin Lymphoma | Relapsed Non Hodgkin Lymphoma | Aggressive Non-Hodgkin LymphomaUnited States
-
National Cancer Center, KoreaRecruitingRelapsed/Refractory Classical Hodgkin LymphomaKorea, Republic of
-
Canadian Cancer Trials GroupMerck Sharp & Dohme LLC; Seagen Inc.Recruiting
-
Hoffmann-La RocheRecruitingNon-Hodgkin LymphomaUnited States, Korea, Republic of, China, Mexico, Japan, Brazil, Argentina, Thailand, Canada, Peru, Turkey, Russian Federation, Israel, New Zealand
-
University of WashingtonGenentech, Inc.RecruitingMarginal Zone Lymphoma | Non-Hodgkin Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Grade 3a Follicular Lymphoma | Indolent B-Cell Non-Hodgkin Lymphoma | Recurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue | Refractory Extranodal Marginal Zone...United States
-
Lawson Health Research InstituteSeagen Inc.RecruitingDiffuse Cutaneous Systemic SclerosisCanada
-
Merck Sharp & Dohme LLCRecruitingDiffuse Large B-Cell Lymphoma | DLBCLPoland, United States, France, Israel, Italy, Turkey, Korea, Republic of, United Kingdom, Thailand, China, Canada